載入...

Comparative Efficacy of Olmesartan, Losartan, Valsartan, and Irbesartan in the Control of Essential Hypertension

In a multicenter, randomized, double‐blind trial, the authors compared the antihypertensive efficacy of once‐daily treatment with the new angiotensin II type 1 receptor blocker (ARB) olmesartan (20 mg) with recommended starting doses of losartan (50 mg), valsartan (80 mg), and irbesartan (150 mg) in...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Clin Hypertens (Greenwich)
Main Authors: Oparil, Suzanne, Williams, David, Chrysant, Steven G., Marbury, Thomas C., Neutel, Joel
格式: Artigo
語言:Inglês
出版: Le Jacq Communications, Inc. 2007
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8101821/
https://ncbi.nlm.nih.gov/pubmed/11588406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1524-6175.2001.01136.x
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!